TiumBio Presents Phase 1b Interim Results for TU2218 in Combination with Pembrolizumab at ASCO 2024 Annual Meeting

PR Newswire
June 1, 2024 — 20:00 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: America investment South Korea United States Website

Related News:

Desay Battery Highlights Advanced Energy Solutions at RE+ 2024

September 11, 2024 — 03:00

Transcenta Holding Limited (Stock Code: 6628.HK) Announce 2024 Interim Results

August 29, 2024 — 14:31

Telin and Indosat Ooredoo Hutchison Partner to Develop the Indonesia Cable System Express 2 (ICE System 2)

August 28, 2024 — 20:46

Hyundai Motor Group Companies’ Ratings Upgraded by Global Top Rating Agencies

August 26, 2024 — 17:24

WSPN Appoints Ex-Visa President John Partridge as Board Director

August 22, 2024 — 11:22

2024 World Life Science Conference Scheduled for October 19 in Hainan, China

August 18, 2024 — 20:20

PRA Group Leader Wins Silver Stevie Award in 2024 International Business Awards

August 16, 2024 — 06:31

Lumary Launches New Smart UFO LED High Bay Light

July 20, 2024 — 19:15

Viomi Technology Co., Ltd Enters Definitive Agreements to Divest Certain IoT@Home Businesses in an Effort to Strategically Focus on Home Water Solution Businesses

July 20, 2024 — 04:05

Franchising and Licensing Asia (FLAsia) 2024